Nevertheless, tumor xenograft models fostering a heterogeneous tumor microenvironment may be required for testing the antitumor effect of JUN inhibition, as the JUN activity is also elevated in tumor fibroblasts (Figure 6E, F). Here, JUN is linked to neoplasm.